Published in
Wiley, British Journal of Haematology, 1(180), p. 41-51
DOI: 10.1111/bjh.14987
Links
Tools
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results
Journal article published in 2017 by
Andrew Spencer,
Simon Harrison,
Jeffrey Zonder,
Ashraf Badros,
Jacob Laubach 
,
Krystal Bergin,
Amit Khot ,
Todd Zimmerman,
Dharminder Chauhan,
Nancy Levin,
Ann MacLaren ,
Steven D. Reich,
Mohit Trikha,
Paul Richardson
,
Krystal Bergin,
Amit Khot ,
Todd Zimmerman,
Dharminder Chauhan,
Nancy Levin,
Ann MacLaren ,
Steven D. Reich,
Mohit Trikha,
Paul Richardson
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 